More than 50 countries and international organisations worldwide are currently working on
strategies and policies to promote a transition to a bioeconomy. This economic system …

Background Social scientists have paid increasing attention to health technology
assessment (HTA). This paper provides an overview of existing social scientific literature on …

Whilst basic science rapidly produces new insights into the biological determinants of
human health and disease, clinical innovation is often said to lag behind, as it fails to rapidly …

Regenerative medicine (RM) is championed as a potential source of curative treatments for
a variety of illnesses, and as a generator of economic wealth and prosperity. Alongside this …

This book provides new insights into how new biology, and the emergence of" translational"
policies to drive the health bioeconomy, is reshaping the innovation ecosystem for new …

This essay reviews work in sociology and cognate fields regarding pharmaceutical
marketing and its regulation. In particular, it considers how this literature contributes to a …

Social studies of biomedicine often focus on how exogenous policies shape the medical
domain. While policy agendas no doubt affect complex biomedical projects, in the present …

Pharmacogenetic tests provide genetic data to tailor drug treatment and were widely
predicted to be one of the first fruits of the Human Genome Project. In the mid‐2000s, the US …

The objective of this article is to assess the dominant global economic system and the
resulting power relations from the perspective of the strategies used worldwide against the …

Before the Covid-19 pandemic brought the proprietary pharmaceutical sector to the attention
of the lay public, scholars had constructed a rich body of knowledge covering almost all of its …